Drug makers Glenmark, Aurobindo recall products in USGlenmark Pharmaceuticals Inc, USA is recalling Fulvestrant injection, Naproxen Sodium Tablets, Chlorzoxazone tablets and Arformoterol Tartr...
Wockhardt shares climb 2% after USFDA makes nil observationIn a regulatory filing, the company said no observations were made after the US drug regulator inspected its Bioequivalence centre.
Cipla gets USFDA nod for hypertension, cardiac drugCipla said, Metoprolol succinate extended-release tablets are indicated for the treatment of hypertension, to lower blood pressure, Angina ...
Cadila Healthcare soars over 4% post USFDA drug nodCLSA has upgraded Cadila Healthcare to ‘buy’ from ‘underperform’.
Zydus Cadila gets USFDA nod for cardiac drugThe product will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad, Zydus Cadila said in a statement.
- Neutral Dr Reddy's Laboratories, target Rs 3070: Credit Suisse
The global brokerage firm expects competition in Metoprolol and Decitabine over 12-18 months. Some clarity on Copaxone will come from Paten...
Wockhardt surges 11% as USFDA completes inspection in two Maharashtra plantsWockhardt Ltd closed the day on BSE at Rs 1,575.05; up 10.67%. The stock surged as much as 11.57 per cent in intraday trade after reports t...
Wockhardt, Cadila and Hospira voluntarily recall drugs in USDrug firms Wockhardt, Cadila Healthcare and Hospira are voluntarily recalling certain lots of drugs in US, according to the US Food and Dru...
Dr Reddy's recalls over 13,000 bottles of hypertension drug: FDADr Reddy's Laboratories Ltd is recalling 13,560 bottles of the high blood pressure drug metoprolol succinate in US after it failed a dissol...
Wockhardt recalls 8,712 bottles of hypertension drug in US marketWockhardt is recalling over 8,000 bottles of anti-hypertension drug Metoprolol Succinate extended-release tablets following failure of a di...
Wockhardt recalls over 109,000 bottles of hypertension drug in USWockhardt Ltd is recalling 109,744 bottles of a high blood pressure drug in the US after it failed a dissolution test, the US Food and Drug...
Wockhardt's Chikalthana plant hit by USFDA import restrictionsIn May, the USFDA had also issued an import alert on the company's Waluj facility which makes injectables and solid dosages.
- Nomura assigns 'buy' rating on Godrej Consumer
According to Nomura, GCPL now has a well-diversified portfolio and geographical split, which will free the company from its reliance on its...
Six stocks to be in focus on Wednesday morning tradeThe Sensex gained momentum on Wednesday after a positive start. Here are the stocks that are likely to be in action in trade today.
- Dr Reddy's launches high blood pressure tablets in US market
Dr Reddy's Laboratories today said it has launched Metoprolol Succinate tablets used for treating high blood pressure in the American marke...
Hard work pays off for Wockhardt: Habil Khorakiwala, Chairman, WockhardtWockhardt has about 70% of its sales accruing from overseas, mostly the US. Hedging is par for the course for companies with forex exposure.
- Wockhardt gets US FDA approval for generic version of ToprolXL
Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for...